Mato, Anthony R <br/><br/>
Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  07 2020 
 - 3589-3596 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Comment 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-19-3815  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bridged Bicyclo Compounds, Heterocyclic<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Phosphatidylinositol 3-Kinases<br/>Protein Kinase Inhibitors--adverse effects<br/>Pyrazoles<br/>Pyrimidines<br/>Sulfonamides